334 related articles for article (PubMed ID: 1331327)
1. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
Nijssen PC; Sexton T; Childers SR
J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
[TBL] [Abstract][Full Text] [Related]
2. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase.
Childers SR
J Neurochem; 1988 Feb; 50(2):543-53. PubMed ID: 2826699
[TBL] [Abstract][Full Text] [Related]
3. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain.
Childers SR; Fleming L; Konkoy C; Marckel D; Pacheco M; Sexton T; Ward S
Ann N Y Acad Sci; 1992 Jun; 654():33-51. PubMed ID: 1321574
[TBL] [Abstract][Full Text] [Related]
4. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
5. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
7. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
9. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
Cruciani RA; Lutz RA; Munson PJ; Rodbard D
J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
[TBL] [Abstract][Full Text] [Related]
10. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
11. Activation of opioid and muscarinic receptors stimulates basal adenylyl cyclase but inhibits Ca2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb.
Olianas MC; Onali P
J Neurochem; 1994 Jul; 63(1):161-8. PubMed ID: 8207425
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
Niroomand F; Mura RA; Piacentini L; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
[TBL] [Abstract][Full Text] [Related]
13. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
[TBL] [Abstract][Full Text] [Related]
14. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotide regulation of [125I]beta-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements.
Selley DE; Bidlack JM
Brain Res; 1989 Jul; 493(1):23-32. PubMed ID: 2550106
[TBL] [Abstract][Full Text] [Related]
16. Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord.
Reddy PL; Bhargava HN
Peptides; 1996; 17(4):625-8. PubMed ID: 8804072
[TBL] [Abstract][Full Text] [Related]
17. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
[TBL] [Abstract][Full Text] [Related]
18. Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase.
Law PY; Wu J; Koehler JE; Loh HH
J Neurochem; 1981 May; 36(5):1834-46. PubMed ID: 7241139
[TBL] [Abstract][Full Text] [Related]
19. Relationship between opioid-receptor occupancy and stimulation of low-Km GTPase in brain membranes.
Clark MJ; Nordby GL; Medzihradsky F
J Neurochem; 1989 Apr; 52(4):1162-9. PubMed ID: 2538562
[TBL] [Abstract][Full Text] [Related]
20. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
